Precision Cancer Medicine
Search All News
"Precision cancer medicine needs to be envisioned as understanding how cancer works, which goes far beyond individual gene mutations." Read Dr. Bass' Disruptors column for the HICCC.
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
Five teams of researchers are awarded pilot grants to conduct innovative basic science, translational, and clinical research across multiple diseases.
- May 11, 2021
In a new study by Adam Bass, MD, scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
Source:CUIMC NewsroomOctober 29, 2020
Adam Bass, MD, joins the HICCC as the founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.